TFRC and melanoma: In mouse models of melanoma and colon cancer, anti-PD-1 treatment induced the expansion of tumor Tregs with a follicular phenotype (Follicular regulatory T cells or Tfr, Foxp3+ Bcl6+), and Tfr depletion by pretreatment with anti-CTLA4 improved tumor control.